Development of non-invasive biomarkers for pre-eclampsia through data-driven cardiovascular network models

Sci Rep. 2024 Oct 4;14(1):23144. doi: 10.1038/s41598-024-72832-y.

Abstract

Computational models can be at the basis of new powerful technologies for studying and classifying disorders like pre-eclampsia, where it is difficult to distinguish pre-eclamptic patients from non-pre-eclamptic based on pressure when patients have a track record of hypertension. Computational models now enable a detailed analysis of how pregnancy affects the cardiovascular system. Therefore, new non-invasive biomarkers were developed that can aid the classification of pre-eclampsia through the integration of six different measured non-invasive cardiovascular signals. Datasets of 21 pregnant women (no early onset pre-eclampsia, n = 12; early onset pre-eclampsia, n = 9) were used to create personalised cardiovascular models through computational modelling resulting in predictions of blood pressure and flow waveforms in all major and minor vessels of the utero-ovarian system. The analysis performed revealed that the new predictors PPI (pressure pulsatility index) and RI (resistance index) calculated in arcuate and radial/spiral arteries are able to differentiate between the 2 groups of women (t-test scores of p < .001) better than PI (pulsatility index) and RI (Doppler calculated in the uterine artery) for both supervised and unsupervised classification. In conclusion, two novel high-performing biomarkers for the classification of pre-eclampsia have been identified based on blood velocity and pressure predictions in the smaller placental vasculatures where non-invasive measurements are not feasible.

Keywords: Clinical diagnosis; Digital twin; Hypertension; Machine learning; Pregnancy; Pulse wave velocity; Uterine doppler waveforms.

MeSH terms

  • Adult
  • Biomarkers*
  • Blood Flow Velocity
  • Blood Pressure
  • Female
  • Humans
  • Models, Cardiovascular
  • Pre-Eclampsia* / diagnosis
  • Pre-Eclampsia* / physiopathology
  • Pregnancy

Substances

  • Biomarkers